Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium species.

Tyrrell KL, Citron DM, Warren YA, Goldstein EJ.

Antimicrob Agents Chemother. 2012 Apr;56(4):2194-7. doi: 10.1128/AAC.06274-11. Epub 2012 Jan 30.

2.

Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods.

Tyrrell KL, Warren YA, Citron DM, Goldstein EJ.

Anaerobe. 2011 Jun;17(3):130-4. doi: 10.1016/j.anaerobe.2011.04.002. Epub 2011 Apr 20.

PMID:
21527349
3.

Activity of Ceftaroline against Aerobic Gram-Positive and Gram-Negative Pathogens: Effect of Test Method Variability.

Citron DM, Warren YA, Tyrrell KL, Goldstein EJ.

ISRN Microbiol. 2011 Nov 17;2011:787290. doi: 10.5402/2011/787290. Print 2011.

4.

Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile.

Goldstein EJ, Citron DM, Tyrrell KL, Warren YA.

Anaerobe. 2010 Jun;16(3):220-2. doi: 10.1016/j.anaerobe.2009.12.002. Epub 2010 Jan 4.

PMID:
20044011
5.

Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria.

Citron DM, Warren YA, Tyrrell KL, Merriam V, Goldstein EJ.

J Antimicrob Chemother. 2009 May;63(5):972-6. doi: 10.1093/jac/dkp037. Epub 2009 Feb 24.

PMID:
19240076
7.

In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2008 Feb;52(2):761-6. Epub 2007 Dec 10.

8.

In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2006 Nov;50(11):3959-62. Epub 2006 Sep 18.

9.

Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2006 Oct;50(10):3507-13. Epub 2006 Aug 28.

10.

Synergistes group organisms of human origin.

Horz HP, Citron DM, Warren YA, Goldstein EJ, Conrads G.

J Clin Microbiol. 2006 Aug;44(8):2914-20.

11.

Anaerobic bacteria cultured from the tongue dorsum of subjects with oral malodor.

Tyrrell KL, Citron DM, Warren YA, Nachnani S, Goldstein EJ.

Anaerobe. 2003 Oct;9(5):243-6.

PMID:
16887710
12.

Bacteriology of human bite wound infections.

Merriam CV, Fernandez HT, Citron DM, Tyrrell KL, Warren YA, Goldstein EJ.

Anaerobe. 2003 Apr;9(2):83-6.

PMID:
16887692
13.

In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens.

Merriam CV, Citron DM, Tyrrell KL, Warren YA, Goldstein EJ.

Int J Antimicrob Agents. 2006 Sep;28(3):244-8. Epub 2006 Jul 27.

PMID:
16875802
14.

In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.

Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez HT.

Antimicrob Agents Chemother. 2006 Aug;50(8):2875-9.

15.

In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes.

Tyrrell KL, Citron DM, Warren YA, Fernandez HT, Merriam CV, Goldstein EJ.

Antimicrob Agents Chemother. 2006 Aug;50(8):2728-31.

16.

Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections.

Warren YA, Tyrrell KL, Citron DM, Goldstein EJ.

J Clin Microbiol. 2006 Jul;44(7):2416-22.

17.

In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.

Goldstein EJ, Citron DM, Vaidya SA, Warren YA, Tyrrell KL, Vreni Merriam C, Fernandez H.

Anaerobe. 2006 Apr;12(2):63-6. Epub 2005 Dec 27.

PMID:
16701615
18.

In vitro activities of tinidazole and metronidazole against Clostridium difficile, Prevotella bivia and Bacteroides fragilis.

Citron DM, Tyrrell KL, Warren YA, Fernandez H, Merriam CV, Goldstein EJ.

Anaerobe. 2005 Dec;11(6):315-7. Epub 2005 Jul 5.

PMID:
16701592
19.

Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2006 Jan;50(1):379-81.

20.

In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.

Goldstein EJ, Citron DM, Warren YA, Tyrrell KL, Merriam CV, Fernandez H.

Antimicrob Agents Chemother. 2006 Jan;50(1):148-55.

21.

Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera.

Warren YA, Citron DM, Merriam CV, Goldstein EJ.

J Clin Microbiol. 2005 Aug;43(8):4041-5.

22.

Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens.

Citron DM, Warren YA, Fernandez HT, Goldstein MA, Tyrrell KL, Goldstein EJ.

J Clin Microbiol. 2005 May;43(5):2485-8.

24.
25.

In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2003 Sep;47(9):3008-11.

26.

In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.

Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H, Goldstein EJ.

Antimicrob Agents Chemother. 2003 Jul;47(7):2334-8.

27.

In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2003 Jan;47(1):337-41. Erratum in: Antimicrob Agents Chemother. 2003 Apr;47(4):1486.

28.

In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2002 Dec;46(12):3995-6.

29.
30.

In vitro activities of garenoxacin (BMS-284756) against 170 clinical isolates of nine Pasteurella species.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT.

Antimicrob Agents Chemother. 2002 Sep;46(9):3068-70.

31.

In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez H.

Antimicrob Agents Chemother. 2002 Apr;46(4):1141-3.

32.

Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez H.

Antimicrob Agents Chemother. 2002 Apr;46(4):1136-40.

33.

In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.

Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez H.

Antimicrob Agents Chemother. 2002 Mar;46(3):866-70.

34.

Supplemental Content

Loading ...
Support Center